238 related articles for article (PubMed ID: 33381042)
21. Availability, prices and affordability of essential medicines: A cross-sectional survey in Hanam province, Vietnam.
Nguyen HTT; Dinh DX; Nguyen TD; Nguyen VM
PLoS One; 2021; 16(11):e0260142. PubMed ID: 34793554
[TBL] [Abstract][Full Text] [Related]
22. A comprehensive survey of cancer medicines prices, availability and affordability in Ghana.
Ocran Mattila P; Biritwum RB; Babar ZU
PLoS One; 2023; 18(5):e0279817. PubMed ID: 37134123
[TBL] [Abstract][Full Text] [Related]
23. Impact of National Drug Pricing Policy 2018 on access to medicines in Lahore division, Pakistan: a pre-post survey study using WHO/HAI methodology.
Saeed A; Saeed H; Saleem Z; Yang C; Jiang M; Zhao M; Ji W; Aziz MM; Khan FU; Gillani AH; Atif N; Fang Y; Babar ZUD
BMJ Open; 2020 Oct; 10(10):e034720. PubMed ID: 33033079
[TBL] [Abstract][Full Text] [Related]
24. Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India.
Satheesh G; Sharma A; Puthean S; Ansil T P M; E J; Raj Mishra S; Unnikrishnan MK
Trop Med Int Health; 2020 Dec; 25(12):1467-1479. PubMed ID: 32959441
[TBL] [Abstract][Full Text] [Related]
25. Retail pharmacy prescription medicines' availability, prices and affordability in Eswatini.
Shambira G; Suleman F
Afr J Prim Health Care Fam Med; 2021 Sep; 13(1):e1-e11. PubMed ID: 34636605
[TBL] [Abstract][Full Text] [Related]
26. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
Ewen M; Zweekhorst M; Regeer B; Laing R
PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
[TBL] [Abstract][Full Text] [Related]
27. Access and Affordability of Medicines in Malaysia: Need for a National Pricing Policy.
Wong SL; Ibrahim S; Abdul Kadir N; Mohd Salleh S
Appl Health Econ Health Policy; 2019 Oct; 17(5):641-654. PubMed ID: 31093937
[TBL] [Abstract][Full Text] [Related]
28. Where are we now: assessing the price, availability and affordability of essential medicines in Delhi as India plans free medicine for all.
Kotwani A
BMC Health Serv Res; 2013 Jul; 13():285. PubMed ID: 23885985
[TBL] [Abstract][Full Text] [Related]
29. A survey of the availability, prices and affordability of essential medicines in Jiangsu Province, China.
Xi X; Li W; Li J; Zhu X; Fu C; Wei X; Chu S
BMC Health Serv Res; 2015 Aug; 15():345. PubMed ID: 26310243
[TBL] [Abstract][Full Text] [Related]
30. A national survey on availability, price and affordability of selected essential medicines for non communicable diseases in Sri Lanka.
Dabare PR; Wanigatunge CA; Beneragama BH
BMC Public Health; 2014 Aug; 14():817. PubMed ID: 25103467
[TBL] [Abstract][Full Text] [Related]
31. Price, availability and affordability of medicines.
Mhlanga BS; Suleman F
Afr J Prim Health Care Fam Med; 2014 Jun; 6(1):E1-6. PubMed ID: 26245401
[TBL] [Abstract][Full Text] [Related]
32. Prices, Availability and Affordability of Medicines with Value-Added Tax Exemption: A Cross-Sectional Survey in the Philippines.
Lambojon K; Chang J; Saeed A; Hayat K; Li P; Jiang M; Atif N; Desalegn GK; Khan FU; Fang Y
Int J Environ Res Public Health; 2020 Jul; 17(14):. PubMed ID: 32708060
[TBL] [Abstract][Full Text] [Related]
33. Is the Brazilian pharmaceutical policy ensuring population access to essential medicines?
Bertoldi AD; Helfer AP; Camargo AL; Tavares NU; Kanavos P
Global Health; 2012 Mar; 8():6. PubMed ID: 22436555
[TBL] [Abstract][Full Text] [Related]
34. Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia.
Babar ZU; Ibrahim MI; Singh H; Bukahri NI; Creese A
PLoS Med; 2007 Mar; 4(3):e82. PubMed ID: 17388660
[TBL] [Abstract][Full Text] [Related]
35. Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology.
Kasonde L; Tordrup D; Naheed A; Zeng W; Ahmed S; Babar ZU
BMC Health Serv Res; 2019 Jun; 19(1):383. PubMed ID: 31196078
[TBL] [Abstract][Full Text] [Related]
36. What Factors Hindered the Access to Essential Anticancer Medicine in Public Hospitals for the Local Population in Hubei Province, China.
Chen C; Feng Z; Ding Y; Yan Z; Wang J; Wang R; Feng D
Front Pharmacol; 2021; 12():734637. PubMed ID: 34630110
[No Abstract] [Full Text] [Related]
37. Insulin prices, availability and affordability: a cross-sectional survey of pharmacies in Hubei Province, China.
Liu C; Zhang X; Liu C; Ewen M; Zhang Z; Liu G
BMC Health Serv Res; 2017 Aug; 17(1):597. PubMed ID: 28836974
[TBL] [Abstract][Full Text] [Related]
38. A national survey of price and affordability of key essential medicines for children in Sri Lanka.
Balasubramaniam R; Benaragama BV; Sri Ranganathan S
Indian J Pediatr; 2014 Apr; 81(4):362-7. PubMed ID: 23640698
[TBL] [Abstract][Full Text] [Related]
39. Prices, availability and affordability of medicines in Rwanda.
Bizimana T; Kayumba PC; Heide L
PLoS One; 2020; 15(8):e0236411. PubMed ID: 32745100
[TBL] [Abstract][Full Text] [Related]
40. Pricing and availability of some essential child specific medicines in Odisha.
Swain TR; Rath B; Dehury S; Tarai A; Das P; Samal R; Samal S; Nayak H
Indian J Pharmacol; 2015; 47(5):496-501. PubMed ID: 26600637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
